464 related articles for article (PubMed ID: 30828062)
1. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
Fukuta T; Ishii T; Asai T; Oku N
Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
[TBL] [Abstract][Full Text] [Related]
3. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
Fukuta T
Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
[TBL] [Abstract][Full Text] [Related]
4. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
Fukuta T; Kogure K
Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis.
Fukuta T; Yanagida Y; Asai T; Oku N
Biochem Biophys Res Commun; 2018 Jan; 495(1):873-877. PubMed ID: 29162447
[TBL] [Abstract][Full Text] [Related]
6. Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions.
Fukuta T; Ishii T; Asai T; Sato A; Kikuchi T; Shimizu K; Minamino T; Oku N
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):1-7. PubMed ID: 26455340
[TBL] [Abstract][Full Text] [Related]
7. Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke.
Fukuta T; Oku N; Kogure K
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214092
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil.
Fukuta T; Asai T; Sato A; Namba M; Yanagida Y; Kikuchi T; Koide H; Shimizu K; Oku N
Int J Pharm; 2016 Jun; 506(1-2):129-37. PubMed ID: 27107903
[TBL] [Abstract][Full Text] [Related]
9. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
10. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietin.
Ishii T; Asai T; Oyama D; Fukuta T; Yasuda N; Shimizu K; Minamino T; Oku N
J Control Release; 2012 May; 160(1):81-7. PubMed ID: 22342472
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced.
Ishii T; Fukuta T; Agato Y; Oyama D; Yasuda N; Shimizu K; Kawaguchi AT; Asai T; Oku N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1201-5. PubMed ID: 23268342
[TBL] [Abstract][Full Text] [Related]
13. Nasal Delivery of Antioxidants by Cholesterol-incorporated Liposomes Extends the Neuroprotective Time Window in Cerebral Ischemia.
Min SK; Kwon YS; Cho MK; Shin HS
Curr Pharm Des; 2017; 23(40):6223-6230. PubMed ID: 28847301
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions.
Kikuchi T; Fukuta T; Agato Y; Yanagida Y; Ishii T; Koide H; Shimizu K; Oku N; Asai T
J Pharm Sci; 2019 Dec; 108(12):3823-3830. PubMed ID: 31520645
[TBL] [Abstract][Full Text] [Related]
15. Recanalization and reperfusion therapies for acute ischemic stroke.
Molina CA; Alvarez-Sabín J
Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
[TBL] [Abstract][Full Text] [Related]
16. Advanced drug delivery system against ischemic stroke.
Zhang S; Zhou Y; Li R; Chen Z; Fan X
J Control Release; 2022 Apr; 344():173-201. PubMed ID: 35248645
[TBL] [Abstract][Full Text] [Related]
17. Enhanced brain delivery of hypoxia-sensitive liposomes by hydroxyurea for rescue therapy of hyperacute ischemic stroke.
Wang K; Zhou W; Jin X; Shang X; Wu X; Wen L; Li S; Hong Y; Ke J; Xu Y; Yuan H; Hu F
Nanoscale; 2023 Jul; 15(27):11625-11646. PubMed ID: 37377137
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery systems for the treatment of ischemic stroke.
Rhim T; Lee DY; Lee M
Pharm Res; 2013 Oct; 30(10):2429-44. PubMed ID: 23307348
[TBL] [Abstract][Full Text] [Related]
19. Systemic reperfusion therapy in acute ischemic stroke.
Martínez-Sánchez P; Díez-Tejedor E; Fuentes B; Ortega-Casarrubios MA; Hacke W
Cerebrovasc Dis; 2007; 24 Suppl 1():143-52. PubMed ID: 17971650
[TBL] [Abstract][Full Text] [Related]
20. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
